National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

paliferminPatient Information
A recombinant form of the endogenous human keratinocyte growth factor. Palifermin binds to epithelial cell surface receptors in the lining of the mouth and gastrointestinal tract, resulting in stimulation of epithelial cell proliferation, differentiation and upregulation of cytoprotective mechanisms. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:growth factor, recombinant human keratinocyte
keratinocyte growth factor, recombinant human
recombinant human keratinocyte growth factor
rhu keratinocyte growth factor
US brand name:Kepivance
Abbreviation:rhKGF



Previous:paclitaxel-loaded polymeric micelle, padeliporfin, PADRE 965.10, PADRE-CMV fusion peptide vaccine, Palestrol
Next:palifosfamide, Pallace, palladium Pd 103, palladium-bacteriopheophorbide, palonosetron hydrochloride

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov